Asian shares slid to their lowest in six months, on signs U.S. trade battles with China and many other countries are starting to chip away at corporate profits.
A lull in the Sino-US trade tussle helps calm nerves, while tension in the oil market grows ahead of an OPEC meeting that may expand crude supply
Indian shares were set to snap a two-day losing streak, led by gains in financials, despite lingering trade tensions between US and China that roiled markets.
Investors' improved risk appetite pushes the stocks higher, despite the fears of a full-scale trade war between the United States and China
Chinese stocks fell almost 4 percent and alarm bells rang across global markets on Tuesday, as the trade dispute between the United States and China escalated further.
Stocks slide more as President Trump threatens new tariffs on Chinese goods in an escalating tit-for-tat trade dispute
China’s listed companies must strengthen efforts at “Communist Party building” among other measures to improve corporate governance.
Indian shares fell, in line with Asian peers, as the Federal Reserve raised US interest rates and struck a more hawkish tone in forecasting a slightly faster pace of tightening.
Asian shares eased after the Federal Reserve raised interest rates and took a more hawkish tone in forecasting a slightly faster pace of tightening.
World stocks slipped as expectations of trade tensions dominating this weekend’s summit of G7, along with renewed talk of monetary tightening by major central banks, weighed on risk sentiment.
JSW Steel Limited
May bid for Arcelor-Mittal's Romanian plant
Gets DCGI's marketing nod for key cancer drug
Inks 5-year I.T. Infra deal with Nokia
BANK OF MAHARASHTRA
To raise Rs 3,000 Crore equity capital
Plans to launch 50 cvs this fiscal
Company may bid for Arcelormittal's Romanian plantco
Proposes investment of $500 Mn to upgrade steel manufacturing unit at Ohio, USA
Integrated steel manufacturing unit in Ohio, with potential capacity of 3 MTPA
Company gets marketing nod for Durvalumab drug from DCGI
Durvalumab is a patented product of AstraZeneca Global
Permission significant for patients with limited treatment options
Nokia signs 5-year global I.T. Infra & application services deal with company
Company will transition services from four incumbent vendors
Will build on strong existing engineering-centric partnership with this deal worth $500 Mn
BANK OF MAHARASHTRA
Gets shareholders' nod for raising equity capital upto Rs 3,000 Cr
Bank union requests govt to intervene in bank's arrests
AIBEA writes to DFS secy to step-in to save bank's reputation
May have rotating chairman till full time chairman is appointed
U.S. Investors of bank want Kochhar to quit
Investors will be confident if external candidate is appointed as CEO: Macquarie
TOI & ET REPORTS